These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 404132)
1. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. Brodie AM; Schwarzel WC; Shaikh AA; Brodie HJ Endocrinology; 1977 Jun; 100(6):1684-95. PubMed ID: 404132 [TBL] [Abstract][Full Text] [Related]
2. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats. Brueggemeier RW; Li PK Cancer Res; 1988 Dec; 48(23):6808-10. PubMed ID: 3141048 [TBL] [Abstract][Full Text] [Related]
3. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model. Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949 [TBL] [Abstract][Full Text] [Related]
4. The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors. Abul-Hajj YJ J Steroid Biochem; 1989; 34(1-6):439-42. PubMed ID: 2516585 [TBL] [Abstract][Full Text] [Related]
5. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors. Wing LY; Garrett WM; Brodie AM Cancer Res; 1985 Jun; 45(6):2425-8. PubMed ID: 3921242 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor. Zimniski SJ; Brandt ME; Covey DF; Puett D Breast Cancer Res Treat; 1993; 26(1):15-21. PubMed ID: 8400320 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats. Iino Y; Karakida T; Sugamata N; Andoh T; Takei H; Takahashi M; Yaguchi S; Matsuno T; Takehara M; Sakato M; Kawashima S; Morishita Y Anticancer Res; 1998; 18(1A):171-6. PubMed ID: 9568073 [TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitors--IV. Regression of hormone-dependent, mammary tumors in the rat with 4-acetoxy-4-androstene-3,17-dione. Brodie AM; Marsh D; Brodie HJ J Steroid Biochem; 1979 Apr; 10(4):423-9. PubMed ID: 109701 [No Abstract] [Full Text] [Related]
9. Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors. Rowlands MG; Foster AB; Mann J; Pietrzak B; Wilkinson J; Coombes RC Steroids; 1987; 49(4-5):371-82. PubMed ID: 3455049 [TBL] [Abstract][Full Text] [Related]
10. Effect of an aromatase inhibitor, 1,4,6-androstatriene-3,17-dione, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat and its mechanism of action in vivo. Brodie AM; Brodie HJ; Garrett WM; Hendrickson JR; Marsh DA; Tsai-Morris CH Biochem Pharmacol; 1982 Jun; 31(11):2017-23. PubMed ID: 6810900 [TBL] [Abstract][Full Text] [Related]
11. Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors. Brodie AM; Santen RJ Crit Rev Oncol Hematol; 1986; 5(4):361-96. PubMed ID: 3094971 [TBL] [Abstract][Full Text] [Related]
12. Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione. Covey DF; Hood WF Mol Pharmacol; 1982 Jan; 21(1):173-80. PubMed ID: 7132956 [No Abstract] [Full Text] [Related]
13. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo. Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH; Marcotte PA; Robinson CH Steroids; 1981 Dec; 38(6):693-702. PubMed ID: 7336466 [TBL] [Abstract][Full Text] [Related]
14. Aromatase inhibitors III. Studies on the antifertility effect of 4-acetoxy-4-androstene-3,17-dione. Brodie AM; Wu JT; Marsh DA; Brodie HJ Biol Reprod; 1978 Apr; 18(3):365-70. PubMed ID: 566576 [No Abstract] [Full Text] [Related]
15. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors. Nishino Y; Schneider MR; Michna H; el Etreby MF J Steroid Biochem; 1989; 34(1-6):435-7. PubMed ID: 2533949 [TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat. Yamamoto T; Urabe M; Tamura T; Kitawaki J; Honjo H; Okada H Anticancer Res; 1991; 11(6):1999-2002. PubMed ID: 1776832 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of peripheral aromatization by aromatase inhibitors, 4-hydroxy- and 4-acetoxy-androstene-3,17-dione. Brodie AM; Longcope C Endocrinology; 1980 Jan; 106(1):19-21. PubMed ID: 6765930 [TBL] [Abstract][Full Text] [Related]
18. Antifertility effects of an aromatase inhibitor, 1,4,6-androstatriene-3, 17-dione. Brodie AM; Wu JT; Marsh DA; Brodie HJ Endocrinology; 1979 Jan; 104(1):118-21. PubMed ID: 446339 [TBL] [Abstract][Full Text] [Related]
19. Differential responses of sex steroid target tissues of rats treated with 4-hydroxyandrostenedione. Wing LY; Hammond JO; Brodie AM Endocrinology; 1988 Jun; 122(6):2418-27. PubMed ID: 3131115 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative. Zimniski SJ; Brandt ME; Covey DF; Puett D Steroids; 1987; 50(1-3):135-46. PubMed ID: 3504057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]